FDA Clears Clinical Studies for New Bacteriophage Treatment for Crohn’s Disease

PUBLISHED: November 12, 2018   |  Available Formats  

Global Crohn’s Disease Market – Size, Share and Forecasts (2018-2025)


Tell us what you need!

Report Summary

Crohn’s Disease Market

  • Crohn’s disease (CD) is a chronic inflammatory bowel disease characterized by inflammation of the digestive or gastrointestinal tract.
  • CD most commonly occurs at the end of the small intestine.


Crohn’s disease Market Growth:

  • Global Crohn’s disease (CD) market is estimated to reach USD 13.4 billion by 2026.
  • The market is driven by increasing cases of Crohn’s disease attributed to rapid industrialization as well as unhealthy lifestyle including fast food consumption and smoking habits.
  • Also, growing awareness about the health condition and increasing demand for biologics to cure bowel disorders will further drive the market.
  • However, lack of early diagnosis, the high cost of treatment and patent expiry of blockbuster anti-TNF based drugs may restrain market growth.


Product-based Analysis:

  • Global Crohn’s disease market report segments the market by type, drug class and by region.
  • Based on the part of the GI tract affected, the market is segmented into Ileocolitis, Ileitis, Gastroduodenal Crohn’s disease, Jejunoileitis, and Crohn’s colitis.
  • Ileocolitis is the most common type of Crohn’s disease and affects the small intestine, also known as ileum and colon.
  • Based on the drug type, the market is categorized into anti-diarrheal, anti-inflammatory drugs, immunosuppressors, antibiotics, biologics and pain relievers.
  • Anti-inflammatory drugs segment is expected to exhibit the highest growth over the forecast period.
  • Geographically, the market is segmented into five major regions, namely North America, South America, Europe, Asia Pacific, and RoW.
  • North America is the largest market for Crohn’s disease powered by the growth in the US and Canada.
  • Several studies have shown that Crohn’s disease is becoming more common in children and adults in the US. Approximately 780,000 people in the US have Crohn’s disease.


Market Forecast, By Application

By Type

  • Ileocolitis
  • Ileitis
  • Gastroduodenal Crohn’s disease
  • Jejunoileitis
  • Crohn’s colitis

By Drug Class

  • Anti-diarrheal
  • Anti-inflammatory drugs
  • Immunosuppressors
  • Antibiotics
  • Biologics
  • Pain relievers

By Distribution Channel

  • Hospitals
  • Retail Pharmacy
  • Online Pharmacy

By Region

  • Asia Pacific (China, Japan, India, Australia, Rest of Asia Pacific)
  • Europe (Germany, France, The UK, Italy, Spain, Rest of Europe)
  • North America (The USA, Canada, Mexico)
  • South America (Brazil, Argentina, Rest of South America)
  • Rest of the World


Reasons for purchasing the report?

  • Visualize the composition of Crohn’s disease market across each indication, regarding type and treatment options, highlighting the critical commercial assets and players.
  • Identify commercial opportunities in Crohn’s disease market by analyzing trends and co-development deals.
  • Excel data sheet with thousands of data points of the market – level 4/5 segmentation.
  • PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.
  • Product mapping in excel for critical products of all major market players


Who can benefit from this report?

  • Equipment Suppliers/ Buyers
  • Service Providers/ Buyers
  • Industry Investors/Investment Bankers
  • Education & Research Institutes
  • Research Professionals
  • Emerging Companies
  • Manufacturers

Table of Contents

Crohn’s disease Market

1. Methodology and Scope

1.1 Research Methodology

1.2 Scope of the Report


2.Industry  Trends

2.1 Key Trends & Developments


3. Market Outlook

3.1 Market Drivers

  • Increasing diagnosed prevalent cases of Crohn’s disease
  • Growing awareness about the health condition
  • Increasing demand for biologics to cure bowel disorders

3.2 Market Restraints

    • Lack of early diagnosis
    • High cost of treatment
    • Patent expiry of blockbuster anti TNF based drugs

3.3 Threats and Opportunities

3.4 Porter’s 5 Forces


4. Market Segmentation- By Product and Application 

4.1. Crohn’s disease Market – By Type

  • Ileocolitis
  • Ileitis
  • Gastroduodenal Crohn’s disease
  • Jejunoileitis
  • Crohn’s colitis

4.2 Crohn’s disease Market – By Drug Class

  • Anti-diarrheal
  • Anti-inflammatory drugs
  • Immunosuppressors
  • Antibiotics
  • Biologics
  • Pain relievers

4.3 Crohn’s disease Market – By Distribution Channel

4.3.1 Hospitals

4.3.2 Retail Pharmacy

4.3.3 Online Pharmacy


5. Regional, Country-level Analysis

5.1. North America

5.1.1. The USA

5.1.2. Canada

5.1.3. Mexico

5.2. Europe

5.2.1. Germany

5.2.2. France

5.2.3. The UK

5.2.4. Italy

5.2.5. Spain

5.2.6. Rest of Europe

5.3. Asia Pacific

5.3.1. China

5.3.2. Japan

5.3.3. India

5.3.4. Australia

5.3.5. Rest of Asia Pacific

5.4. South America

5.4.1. Brazil

5.4.2. Argentina

5.4.3. Rest of South America

5.5 Rest of the World


6. Industry Competitiveness

6.1. Market Share Analysis

6.2. Mergers and Acquisitions Analysis

6.3. New Product Launches


7.  Company Profiles

  • AbbVie Inc.
  • Allergan, Inc.
  • Bayer AG
  • Bristol-Myers Squibb
  • Boehringer Ingelheim GmbH
  • Hoffmann-La Roche
  • Eli Lilly and Co.
  • GlaxoSmithKline Plc
  • Janssen Biotech, Inc.
  • Johnson & Johnson
  • Novartis International AG
  • Pfizer Inc.
  • Sanofi
  • Takeda Pharmaceutical Company Limited


8. Appendix

8.1 Sources

8.2 List of Tables

8.3 Expert Panel Validation

8.4 Disclaimer

8.5 Contact Us

Explore our Bundle Subscriptions
  • 1 Year Dedicated Assistance
  • Customisation Unlimited
  • Starting from Bundle of 3 Reports
  • XLS, PPT & PDF formats


Discounts for
New Customers

*Offer valid upto February 14, 2019

Note:  Your Privacy is our main concern  your details are secure with us!




Tell us what you need!